Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Anticancer Research|October 3, 2014
First-line treatment result influence second-line regimen selection in targeted therapy for metastatic renal cell carcinomaJian-Ri Li, Cheng-Kuang Yang, Shian-Shiang Wang, et al.
Urologic Oncology|March 3, 2019
Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survivalSheng-Chun Hung, Shian-Shiang Wang, Jian-Ri Li, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|April 13, 2017
Ureteroscopy-Assisted Laparoscopic Segmental Resection of Ureteral Stricture with a Modified Flank Position: Clinical ExperienceSheng-Chun Hung, Kun-Yuan Chiu, Chen-Li Cheng, et al.
Journal of Cellular and Molecular Medicine|August 3, 2023
Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancerYu-Ching Wen, Chia-Yen Lin, Chi-Hao Hsiao, et al.
Journal of the Chinese Medical Association : JCMA|April 6, 2011
Trends in treatment for localized prostate cancer after emergence of robotic-assisted laparoscopic radical prostatectomy in TaiwanChien-Liang Liu, Chien-Chang Li, Chi-Rei Yang, et al.
International Journal of Medical Sciences|December 28, 2018
Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological CharacteristicsSheng-Chun Hung, Shian-Shiang Wang, Jian-Ri Li, et al.
Frontiers in Immunology|October 20, 2025
Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021)Gu-Shun Lai, Jian-Ri Li, Chuan-Shu Chen, et al.
Urologic Oncology|June 4, 2019
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsyChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Anticancer Research|July 3, 2019
Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center ExperienceLi-Wen Chang, Sheng-Chun Hung, Shian-Shiang Wang, et al.
International Journal of Medical Sciences|December 4, 2024
Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomyYung-Wei Lin, Yu-Ching Wen, Chia-Yen Lin, et al.
Pageof 12